Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

Oral Oncology

Volumn 36, Issue 1, 2000, Pages 100-105

  Werkmeister, R ^a   Brandt, B ^a   Joos, U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

ErbB oncogenes; Oral cancer; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENES, ERBB-1; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 0033990714     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00069-X     Document Type: Article

References (26)

1. Downward J., Yarden Y., Mayes E., Scarce G., Totty N., Stockwell P.et al. Close similarity of epidermal growth actor receptor and v-erb oncogene protein sequences. Nature. 307:1984;521-527.
2. Semba K., Kamata N., Toyoshima K., Yamamoto T. A v-erbB-related protooncogene, c-erbB-2 is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA. 82:1985;6497-6501.
3. Hynes N.E., Stern D.F. The biology of erbB-2/neu/HER and its role in cancer. Biochim Biophys Acta. 1198:1994;165-184.
4. Brandt B., Vogt U., Schlotter C.M., Jackisch C., Werkmeister R., Thomas M.et al. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene. 159:1995;35-42.
5. Eisbruch A., Blick M., Lee J.S., Sacks P.G., Gutterman J. Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors. Cancer Res. 47:1987;3603-3605.
6. Yu D., Hung M.C. The Her-2/neu gene in human cancers. Freirich E.J., Stass S.A. Molecular Basis of Oncology. 1995;131-162 Blackwell Science, Oxford.
7. Yamamoto T., Kamata N., Kawano H. High incidence of amplification of epidermal growth factor receptor gene in human squamous cell lines. Cancer Res. 46:1986;414-416.
8. Shin D.M., Lee J.S., Lippman S.M., Lee J.J., Tu Z.N., Choi G.et al. P53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Ntl Cancer Inst. 88:1996;519-529.
9. Hou L., Shi D., Tu S.M., Zhang H.Z., Hung M.C., Ling D. Oral cancer progression and c-erbB-2/neu proto-oncogene expression. Cancer Letters. 65:1992;215-220.
10. Wilkman T.S.E., Hietanen J.H.P., Malmström M.J., Konttinen Y.T. Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions. Int J Oral Maxillofac Surg. 27:1998;209-212.
11. Wikstrand C.J., Hale L.P., Batra S.K., Hill M.L., Humphrey P.A., Kurpad S.N., McLendon R.E., Moscatello D., Pegram C.N., Reist C.J. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 55:1995;3140-3148.
12. Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., Biegel J.A., Hayes R.L., Wong A.J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55:1995;5536-5539.
13. Lin J.T., Wu M.S., Shun C.T., Lee W.J., Sheu J.C., Wang T.H. Occurrence of microsatellite instability in gastric carcinoma is associated with enhanced expression of c-erbB-2 oncoprotein. Cancer Res. 55:1995;1428-1430.
14. Spiessl B., Beahrs O.H., Hermanek P., Hutter R.V.P., Scheibe O., Sobin L.H.et al. TNM Atlas. 1990;Springer, Heidelberg.
15. TNM-Klassifizierung maligner Tumoren. 1987;Springer, Berlin.
16. Roetger A., Brandt B., Barnekow A. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes. DNA Cell Biol. 16:1997;443-448.
17. Brandt B., Vogt U., Harms F., Bosse U., Zänker K.S., Assmann G. Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content. Gene. 159:1995;29-34.
18. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass. 53:1958;457-481.
19. Cox D.R. Regression models and life-tabels. J R Stat Soc. 34:1972;187-202.
20. Slaughter D.P., Southwick H.W., Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 6:1958;963-968.
21. Voravud N., Shin D.M., Ro J.Y., Lee J.S., Hong W.K., Hittelman W.N. Increased polysomies of chormosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res. 53:1993;2874-2883.
22. Lee J.S., Kim S.Y., Hong W.K., Lippman S.M., Ro J.Y., Gay M.L.et al. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst. 23:1993;1951-1954.
23. Hemprich A, Breier Th, Kovács G. Langzeitergebnisse der radikalen Therapie von Plattenepithelkarzinomen der Mundhöhle unter besonderer Berücksichtigung von Spätrezidiven und Zweitmalignomen - eine Katamnese aus 20 Jahren. Schwenzer, N. Fortschritte der Kiefer- und Gesichts-Chirugie. Stuttgart: Thieme. p. 43-45.
24. Deleyiannis F.W.B., Thomas D.B., Vaughan T.L., Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Nat Cancer Inst. 88:1996;542-549.
25. erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int. J. Cancer. 60:1995;137-144.
26. Schmidt M., Hynes N., Groner B., Wels W. A bivalent single-chain antibody-toxin specific for erbB-2 and the EGF receptor. Int J Cancer. 65:1996;538-546.